Neuralia TMS Expands Access to Innovative OCD Treatment in Australia
Australia, 21st Feb 2025, – Neuralia TMS has announced an expansion of its services to enhance access to transcranial magnetic stimulation (TMS) therapy for individuals living with obsessive-compulsive disorder (OCD) in Australia. This initiative aims to provide additional treatment options for those seeking alternatives to traditional therapies.
OCD is a chronic mental health disorder characterised by persistent thoughts (obsessions) and repetitive behaviours (compulsions). Standard treatment options include cognitive-behavioural therapy and medication, though these approaches may not be effective for all individuals. TMS therapy has been studied as a potential option, with research exploring its impact on reducing OCD symptoms through brain activity modulation.
Neuralia TMS has expand...